Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Vascular endothelial function improvement" refers to the enhancement or restoration of the normal physiological activities of the vascular endothelium, the thin cell layer lining blood vessels. This state is marked by improved balance between vasodilators (notably nitric oxide), vasoconstrictors, and other mediators that regulate vascular tone, thrombosis, inflammation, and permeability. Interventions that improve endothelial function are pursued as preventive and therapeutic strategies for cardiovascular and metabolic diseases, since endothelial dysfunction is a key early event in atherosclerosis, hypertension, diabetes, and other chronic conditions
Increase nitric oxide (NO) bioavailability - Enhance endothelial nitric oxide synthase (eNOS) expression - Reduce oxidative stress - Inhibit endothelial inflammation (e.g., via KLF2/KLF4) - Modulate prostacyclin, EDHF, and endothelin signaling
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelial function improvement.